• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下宿主中传播性多重耐药性甲型流感病毒 A/H3N2 的快速选择。

Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

机构信息

Respiratory Virus Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 3203 33 North Dr, Bethesda, MD 20892-3203, USA.

出版信息

J Infect Dis. 2010 May 1;201(9):1397-403. doi: 10.1086/651610.

DOI:10.1086/651610
PMID:20350163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2851491/
Abstract

BACKGROUND

The overall impact of influenza virus infection in immunocompromised patients is largely unknown. Antigenic drift and genetic variations during prolonged influenza infection have been demonstrated. In this report we describe a multidrug-resistant H3N2 influenza virus isolated from an immunocompromised patient after 5 days of therapy.

METHODS

Multiple nasal wash samples were collected from an infected patient, and viral isolates were characterized. Sensitivity to antiviral agents was evaluated. Fitness and transmissibility were assessed in ferrets and tissue culture.

RESULTS

An in-frame 4-amino acid deletion emerged in the neuraminidase (NA) gene of an H3N2 virus after 5 days of oseltamivir therapy. No other changes in the NA or hemagglutinin genes were noted. Drug sensitivity assays revealed resistance to oseltamivir (>10-fold increase in 50% inhibitory concentration [IC(50)]) and reduction in sensitivity to zanamivir (3-7-fold increase in IC(50) or 50% effective concentration). No change in fitness or transmissibility was observed.

CONCLUSIONS

An in-frame NA gene deletion was rapidly selected for in an immunocompromised patient, resulting in decreased sensitivity of the isolate to available NA inhibitors without a change in fitness or transmissibility. This finding has implications for our understanding of the emergence of antiviral resistance and treatment of patients with influenza A infection, especially those who are immunocompromised.

摘要

背景

流感病毒感染对免疫功能低下患者的整体影响尚不清楚。在长时间的流感感染过程中,病毒发生了抗原漂移和基因变异。在本报告中,我们描述了一例免疫功能低下患者在接受 5 天治疗后分离出的一株多药耐药 H3N2 流感病毒。

方法

从感染患者中采集多个鼻洗液样本,并对病毒分离株进行鉴定。评估了对抗病毒药物的敏感性。在雪貂和组织培养中评估了适应性和传染性。

结果

在奥司他韦治疗 5 天后,一株 H3N2 病毒的神经氨酸酶(NA)基因中出现了 4 个氨基酸的框内缺失。NA 或血凝素基因没有其他变化。药物敏感性检测显示对奥司他韦耐药(50%抑制浓度[IC(50)]增加 10 倍以上)和对扎那米韦敏感性降低(IC(50)或 50%有效浓度增加 3-7 倍)。未观察到适应性或传染性的变化。

结论

在免疫功能低下的患者中,NA 基因的框内缺失迅速被选择,导致分离株对现有 NA 抑制剂的敏感性降低,而适应性或传染性没有变化。这一发现对我们理解抗病毒耐药性的出现和治疗流感 A 感染患者,特别是免疫功能低下的患者具有重要意义。

相似文献

1
Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.免疫功能低下宿主中传播性多重耐药性甲型流感病毒 A/H3N2 的快速选择。
J Infect Dis. 2010 May 1;201(9):1397-403. doi: 10.1086/651610.
2
Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.检测免疫功能低下患者分离的甲型 H3N2 流感病毒中的 E119V 和 E119I 突变:奥司他韦耐药性诊断的挑战。
Antimicrob Agents Chemother. 2010 May;54(5):1834-41. doi: 10.1128/AAC.01608-09. Epub 2010 Mar 1.
3
Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.一名免疫功能低下婴儿体内出现持续排出对金刚烷胺和奥司他韦耐药且具有双重突变的甲型流感病毒(H3N2)的情况。
Antivir Ther. 2010;15(7):1059-63. doi: 10.3851/IMP1657.
4
Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets.大剂量神经氨酸酶蛋白缺失对实验室培养的流感病毒和感染雪貂的流感病毒适应性的影响
Influenza Other Respir Viruses. 2016 Mar;10(2):122-6. doi: 10.1111/irv.12356. Epub 2016 Jan 29.
5
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.一名免疫功能低下儿童一年内排出的耐多药甲型H3N2流感病毒的特征分析
Clin Infect Dis. 2006 Dec 15;43(12):1555-61. doi: 10.1086/508777. Epub 2006 Nov 8.
6
Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada.从2014 - 2015年加拿大艾伯塔省流感季节一名免疫功能低下患者体内分离出的甲型H3N2流感病毒中的奥司他韦耐药性。
Influenza Other Respir Viruses. 2016 Nov;10(6):532-535. doi: 10.1111/irv.12415. Epub 2016 Aug 8.
7
Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.甲型流感病毒的抗病毒敏感性概况;密切关注长期治疗下的免疫功能低下患者。
Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):361-371. doi: 10.1007/s10096-016-2809-3. Epub 2016 Nov 15.
8
Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.甲型 H3N2 流感病毒神经氨酸酶基因缺失和具有缺陷干扰样活性的病毒聚合酶基本 2 RNA 导致的抗病毒耐药性。
J Clin Virol. 2018 May;102:1-6. doi: 10.1016/j.jcv.2018.02.005. Epub 2018 Feb 11.
9
Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.免疫功能低下雪貂感染甲型 H3N2 流感病毒和抗病毒耐药性的出现。
PLoS One. 2018 Jul 19;13(7):e0200849. doi: 10.1371/journal.pone.0200849. eCollection 2018.
10
Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.免疫功能低下的小儿患者在接受两个疗程奥司他韦治疗后出现了具有抗药性的 A(H3N2) 病毒。
Influenza Other Respir Viruses. 2013 Nov;7(6):904-8. doi: 10.1111/irv.12108. Epub 2013 Mar 29.

引用本文的文献

1
A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain.一项在西班牙进行的关于神经氨酸酶突变及S247N突变增加情况的15年研究。
Virus Res. 2025 Aug;358:199599. doi: 10.1016/j.virusres.2025.199599. Epub 2025 Jun 26.
2
Virus Evolution in Prolonged Infections of Immunocompromised Individuals.免疫功能低下个体长期感染中的病毒进化
Clin Chem. 2025 Jan 3;71(1):109-118. doi: 10.1093/clinchem/hvae150.
3
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant.

本文引用的文献

1
Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses - New Zealand, 2009.2009年新西兰甲型H1N1流感大流行病毒及季节性流感病毒监测
MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):918-21.
2
Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.2009年甲型H1N1流感大流行相关死亡病例的流行病学
Euro Surveill. 2009 Aug 20;14(33):19309. doi: 10.2807/ese.14.33.19309-en.
3
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
扎那米韦和巴洛沙韦联合治疗造血干细胞移植后持续性流感和冠状病毒感染。
Int J Antimicrob Agents. 2024 Sep;64(3):107281. doi: 10.1016/j.ijantimicag.2024.107281. Epub 2024 Jul 22.
4
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.大流行一年后:SARS-CoV-2 的短期演变和新谱系的出现。
Infect Genet Evol. 2021 Aug;92:104869. doi: 10.1016/j.meegid.2021.104869. Epub 2021 Apr 26.
5
Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.利用工程化高保真病毒聚合酶开发遗传稳定的减毒流感活疫苗株。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00493-21.
6
Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus.不同药物组合对感染甲型H3N2流感病毒的免疫缺陷小鼠的影响。
Microorganisms. 2020 Dec 11;8(12):1968. doi: 10.3390/microorganisms8121968.
7
Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.异基因造血细胞移植后对具有双重 E119D/R292K 取代的耐帕拉米韦流感 A/H3N2 的患者成功使用巴洛沙韦治疗:一例报告。
BMC Infect Dis. 2020 Jul 6;20(1):478. doi: 10.1186/s12879-020-05205-1.
8
Influenza H1N1 infection in immunocompromised host: A concise review.免疫功能低下宿主中的甲型H1N1流感感染:简要综述。
Lung India. 2019 Jul-Aug;36(4):330-336. doi: 10.4103/lungindia.lungindia_464_18.
9
A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.对同时对奥司他韦和扎那米韦敏感性降低的甲型和乙型临床流感感染的综述
Open Forum Infect Dis. 2017 May 18;4(3):ofx105. doi: 10.1093/ofid/ofx105. eCollection 2017 Summer.
10
Persistent infections in immunocompromised hosts are rarely sources of new pathogen variants.免疫功能低下宿主中的持续性感染很少是新病原体变体的来源。
Virus Evol. 2017 Jul 28;3(2):vex018. doi: 10.1093/ve/vex018. eCollection 2017 Jul.
2009年,华盛顿州西雅图市两名免疫功能低下患者感染对奥司他韦耐药的新型甲型H1N1流感病毒
MMWR Morb Mortal Wkly Rep. 2009 Aug 21;58(32):893-6.
4
A/H1N1 pandemic. Too soon for congratulations.
BMJ. 2009 Aug 11;339:b3248. doi: 10.1136/bmj.b3248.
5
England to launch special flu service next week to take pressure off primary care.
BMJ. 2009 Jul 20;339:b2932. doi: 10.1136/bmj.b2932.
6
How well are we managing the influenza A/H1N1 pandemic in the UK?我们在英国对甲型H1N1流感大流行的应对情况如何?
BMJ. 2009 Jul 15;339:b2897. doi: 10.1136/bmj.b2897.
7
The persistent legacy of the 1918 influenza virus.1918年流感病毒的持续影响。
N Engl J Med. 2009 Jul 16;361(3):225-9. doi: 10.1056/NEJMp0904819. Epub 2009 Jun 29.
8
Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009.2009年4月至5月加利福尼亚州甲型H1N1流感病毒感染住院患者
MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):536-41.
9
Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.更新:2009年5月6日全球甲型H1N1流感病毒感染情况
MMWR Morb Mortal Wkly Rep. 2009 May 8;58(17):453-8.
10
Pandemic influenza: an inconvenient mutation.大流行性流感:一种麻烦的突变。
Science. 2009 Mar 20;323(5921):1560-1. doi: 10.1126/science.323.5921.1560.